Multidrug-resistant tuberculosis in Mumbai: it’s only getting worse. Go to Publication You Might Also Like How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus September 3, 2020 Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay. March 2, 2015 MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network September 3, 2020 Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosages. February 19, 2017 Dual infection with HIV-1 and HIV-2. June 30, 1997
How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus September 3, 2020
Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay. March 2, 2015
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network September 3, 2020
Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosages. February 19, 2017